Salim Hayek
Has participated in:
-
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
-
Prospective cohort study of soluble urokinase plasminogen activation receptor and cardiovascular events in patients with CKD
-
Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD